Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 16, 2019

View Archived Issues

After stroke, neurons grow up too fast

Inhibitory T cells can yield antitumor targeting

New locus found to be tied to erectile dysfunction

Synergistic effect seen for AOA-2, an ompA inhibitor, and colistin against A. baumannii

Bioharmony and Boehringer collaborate to advance bacteriophage lysins for MDR bacterial infections

Pediatric phase III study of Ragwitek sublingual allergy immunotherapy meets primary endpoint

Complutense University of Madrid, University of Santiago de Compostela patent DRD1 PAMs

Deubiquitylating enzyme inhibitors discovered at Mission Therapeutics

Shanghai Institute of Materia Medica describes new antibacterials

Novel irreversible covalent inhibitor of KRAS-G12C demonstrates efficacy in vivo

Abbisko Therapeutics discloses new CSF-1R inhibitors

KCB-3602 demonstrates potential anticancer activity in vitro

New COMT inhibitors described by the Sorbonne and collaborators

In situ-formed therapeutic gel inhibits recurrence at resection site and systemic tumor development

Anti-SIRT1 autoantibodies as a marker for ankylosing spondylitis diagnosis

Muscular Dystrophy Association grant supports AcuraStem's preclinical development of AS-2015 for ALS

TAMs boost tumor hypoxia and aerobic glycolysis

Linzess approved in China for IBS with constipation

Onstryv approved in Canada for Parkinson's disease

Knopp Biosciences expands dexpramipexole research collaboration with Cincinnati Children's Hospital

RaQualia Pharma presents sodiuim ion channel Nav1.7/Nav1.8 blockers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
SKL-35501 shows broad antitumor activity in solid tumors
BioWorld Science
Neurotensin receptor 1 (NTSR1) is overexpressed in several aggressive solid tumors, including colorectal and pancreatic cancer, making it a promising therapeutic...